Literature DB >> 20716996

Baseline infection with a sexually transmitted disease is highly predictive of reinfection during follow-up in Malagasy sex workers.

Abigail Norris Turner1, Paul J Feldblum, Theresa Hatzell Hoke.   

Abstract

Female sex workers who had prevalent chlamydial, gonococcal, or trichomonal infection at enrollment into a randomized trial in Madagascar were 2 to 4 times as likely to become infected during follow-up, compared to women without STIs at baseline, despite provision of condoms, safer sex counseling, and repeat STI testing and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20716996     DOI: 10.1097/OLQ.0b013e3181d70a03

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 2.  Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges.

Authors:  Andreea Waltmann; Tyler R McKinnish; Joseph A Duncan
Journal:  Curr Opin Infect Dis       Date:  2021-02-01       Impact factor: 4.915

3.  High burden of self-reported sexually transmitted infections among female sex workers in Togo in 2021.

Authors:  Alexandra M Bitty-Anderson; Fifonsi A Gbeasor-Komlanvi; Akila W Bakoubayi; Martin K Tchankoni; Arnold J Sadio; Mounerou Salou; Claver A Dagnra; Didier K Ekouevi; Patrick A Coffie
Journal:  Front Public Health       Date:  2022-08-03

4.  High rates of reinfection and incidence of bacterial sexually transmitted infections in a cohort of female sex workers from two Indian cities: need for different STI control strategies?

Authors:  Anjana Das; Anupam Khungar Pathni; Prakash Narayanan; Bitra George; Guy Morineau; Tobi Saidel; Parimi Prabhakar; Gururaj Rao Deshpande; Raman Gangakhedkar; Sanjay Mehendale; Arun Risbud
Journal:  Sex Transm Infect       Date:  2012-11-29       Impact factor: 3.519

5.  Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.

Authors:  Elizabeth M Parzych; Sunita Gulati; Bo Zheng; Mamadou A Bah; Sarah T C Elliott; Jacqueline D Chu; Nancy Nowak; George W Reed; Frank J Beurskens; Janine Schuurman; Peter A Rice; David B Weiner; Sanjay Ram
Journal:  mBio       Date:  2021-03-16       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.